Demonstration Formulary
4 Central nervous system
PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control
04-09-01 Dopamine receptor agonists
| Apomorphine Dacepton® |
|
Formulary
|
|
|
| Pramipexole |
|
Formulary
|
Please note that MODIFIED RELEASE preparation's are non-formulary and for existing patients only |
|
|
| Ropinirole |
|
Formulary
|
For use in Restless Legs, supported by an ESCA, see link below |
 ESCA: Ropinerole in Restless Legs syndrome |
|
Links
- Administration of depot antipsychotic injections during COVID-19 in stable adult patients
- ESCA: Apomorphine
- ESCA: Ropinerole in Restless Legs syndrome
- ESCA: Selegiline
- NICE NG71: Parkinson’s disease in adults
- UKMI Q&A: How do you convert from co-beneldopa (Madopar®) prolonged-release capsules to dispersible tablets?